tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:CYBN Stock Latest News

Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
The FlyPsychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
2M ago
CMPS
DRUG
Three new option listings and four option delistings on January 5th
PremiumThe Fly
Three new option listings and four option delistings on January 5th
2M ago
BFIN
CYBN
Helus Pharma Rebrands, Moves to Nasdaq as It Advances Late-Stage Mental Health Drugs
PremiumCompany Announcements
Helus Pharma Rebrands, Moves to Nasdaq as It Advances Late-Stage Mental Health Drugs
2M ago
CYBN
Cybin to change name, symbol
PremiumThe Fly
Cybin to change name, symbol
2M ago
CYBN
Cybin Launches US$100 Million At-the-Market Equity Program
PremiumCompany Announcements
Cybin Launches US$100 Million At-the-Market Equity Program
2M ago
6K
CYBN
Cybin Sets Up US$100 Million At-the-Market Equity Program With Cantor Fitzgerald
PremiumCompany AnnouncementsCybin Sets Up US$100 Million At-the-Market Equity Program With Cantor Fitzgerald
2M ago
6K
CYBN
Cybin initiates at-the-market equity program of up to $100M
Premium
The Fly
Cybin initiates at-the-market equity program of up to $100M
2M ago
CYBN
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq in Early January
Premium
Company Announcements
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq in Early January
2M ago
6K
CYBN
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq
PremiumCompany Announcements
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq
2M ago
CYBN
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
PremiumThe Fly
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
2M ago
ATAI
CYBN
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq
PremiumCompany Announcements
Cybin to Rebrand as Helus Pharma and Shift U.S. Listing to Nasdaq
3M ago
CYBN
Cybin to transfer U.S. stock exchange listing to Nasdaq
PremiumThe Fly
Cybin to transfer U.S. stock exchange listing to Nasdaq
3M ago
CYBN
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial
PremiumThe FlyPsychedelic: Clearmind completes second cohort enrollment for CMND-100 trial
3M ago
CMND
CYBN
Cybin to Shift U.S. Listing to Nasdaq and Rebrand Ticker as HELP
Premium
Company Announcements
Cybin to Shift U.S. Listing to Nasdaq and Rebrand Ticker as HELP
3M ago
CYBN
Cybin to transfer listing to Nasdaq from NYSE
Premium
The Fly
Cybin to transfer listing to Nasdaq from NYSE
3M ago
CYBN
Psychedelic: Clearmind reports CMND-100 dosing at Hadassah Medical Center
PremiumThe Fly
Psychedelic: Clearmind reports CMND-100 dosing at Hadassah Medical Center
3M ago
CMND
CYBN
Cybin price target raised to $48 from $39 at Guggenheim
PremiumThe Fly
Cybin price target raised to $48 from $39 at Guggenheim
3M ago
CYBN
Cybin Secures $175 Million in Direct Offering to Advance Clinical Programs
PremiumCompany Announcements
Cybin Secures $175 Million in Direct Offering to Advance Clinical Programs
3M ago
6K
CYBN
Psychedelic: Clearmind reports results from first cohort in AUD trial
PremiumThe Fly
Psychedelic: Clearmind reports results from first cohort in AUD trial
3M ago
PBM
CMND
Cybin price target lowered to $45 from $70 at Canaccord
PremiumThe FlyCybin price target lowered to $45 from $70 at Canaccord
3M ago
CYBN
Cybin Inc.: Strategic Positioning and Financial Strength Bolster Buy Rating
Premium
Ratings
Cybin Inc.: Strategic Positioning and Financial Strength Bolster Buy Rating
3M ago
CYBN
Cybin price target lowered to $55 from $150 at H.C. Wainwright
Premium
The Fly
Cybin price target lowered to $55 from $150 at H.C. Wainwright
4M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >